查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612275

心房顫動手術市場：按產品、適應症和最終用戶 - 2025-2030 年全球預測

Atrial Fibrillation Surgery Market by Product (Cardiac Cryoablation Catheters, Cardiac Mapping System), Indication (Atrial Fibrillation (AFib), Atrial Flutter, Supraventricular Tachycardia (SVT)), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，心房顫動手術市場價值為26.7億美元，預計到2024年將達到29億美元，複合年成長率為9.00%，到2030年將達到48.8億美元。

心房顫動 (AF) 手術是一種糾正與心房顫動相關的不規則心率的醫療程序，通常在微創治療失敗時進行。這些手術，如心導管電氣燒灼術和迷宮手術，至關重要，因為心房顫動可導致中風和心臟衰竭等嚴重併發症。其涵蓋範圍涵蓋有症狀的患者和高併發症風險的患者，並得到醫院和心臟專科中心的協助。全球心房顫動手術市場主要受到人口老化以及患者和醫療保健提供者意識不斷提高導致心房顫動盛行率不斷增加的影響。機器人輔助手術和改進的導管設計等創新有可能改善結果並縮短恢復時間。然而，這些程序的高昂成本以及低度開發地區的准入限制阻礙了市場的擴張。監管環境和對熟練專業人員的需求使情況更加複雜。技術共用和培訓方面的策略夥伴關係和合作可能是克服這些障礙的關鍵。在研究和創新方面，人工智慧診斷工具、手術規劃工具和改進的術後監測系統等領域提供了一個有希望的成長途徑。此外，更強大的保險覆蓋範圍和報銷框架可以加速市場開拓。該市場的特點是技術快速進步，但也面臨監管審查，凸顯了合規性和強大的臨床檢驗的必要性。為了獲得市場佔有率，公司必須專注於價值提案，包括具有成本效益的解決方案和改善的患者治療結果。總體而言，研發方面的策略性投資以及擴大患者就診範圍和簡化手術成本的努力對於心房顫動手術市場的持續成長至關重要。

主要市場統計
基準年[2023] 26.7億美元
預測年份 [2024] 29億美元
預測年份 [2030] 48.8億美元
複合年成長率（%） 9.00%

市場動態：快速發展的心房顫動手術市場的關鍵市場洞察

心房顫動手術市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 老年族群中心心房顫動的盛行率上升
    • 心律不整治療中心導管電氣燒灼術偏好的發展
    • 增加心房顫動計畫以提高公眾意識
  • 市場限制因素
    • 與設備相關的監管問題
  • 市場機會
    • 對微創手術、較小的心臟切口和更快的術後恢復時間的需求不斷增加
    • 心房顫動心導管電氣燒灼術技術進展
  • 市場挑戰
    • 缺乏熟練的專業人員和人們對手術的看法

波特五力：駕馭心房顫動手術市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心房顫動手術市場的外部影響

外部宏觀環境因素在塑造心房顫動手術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心房顫動手術市場的競爭格局

對心房顫動手術市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心房顫動手術市場供應商的績效評估

FPNV定位矩陣是評估心房顫動手術市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了心房顫動手術市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對心房顫動手術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人心房顫動盛行率上升
      • 優先發展心導管電氣燒灼術治療心律不整
      • 增加 AF 項目以提高公眾意識
    • 抑制因素
      • 與設備相關的監管問題
    • 機會
      • 對微創手術、較小的心臟切口和更短的術後恢復時間的需求日益成長。
      • 心房顫動心導管電氣燒灼術消融技術進展
    • 任務
      • 缺乏熟練的專業人員和公眾缺乏手術意識
  • 市場區隔分析
    • 產品：隨著基於導管的手術的使用越來越多，對微創手術的需求也在增加。
    • 適應症：迷路手術作為心房顫動的首選治療方法的出現
    • 最終用戶：加速心臟病學和多專科中心進行的心房顫動手術
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心房顫動手術市場：依產品

  • 心臟冷凍消融導管
  • 心臟定位系統

第7章 心房顫動手術市場（按適應症）

  • 心房顫動 (AFib)
  • 心房撲動
  • 心室上性心搏過速 (SVT)

第8章心房顫動手術市場：依最終用戶分類

  • 心臟病學
  • 多專業

第9章北美和南美心房顫動手術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區心房顫動手術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的心房顫動手術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • GE 醫療保健推出用於治療心房顫動的 CardioVisio。它是一種以患者為中心的數位化臨床決策支援工具，可實現精準護理。
    • Biosense Webster 獲得 FDA核准多種心房顫動消融產品，這些產品可用於無需透視的工作流程
    • Medtronic)用於房性心律不整治療的 Aphera 標測和消融系統獲得 CE 標誌核准
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Acesion Pharma ApS
  • Acutus Medical, Inc
  • Affera, Inc.
  • AFreeze GmbH
  • Atrian Medical Ltd.
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • Cardiofocus, Inc.
  • CathRx Ltd
  • Cook Group Incorporated
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies Inc.
  • Healium Medical
  • Japan Lifeline Co.
  • Johnson & Johnson Services, Inc.
  • Kardium Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • OMEICOS Therapeutics GmbH
  • Osypka AG
  • SentiAR, Inc
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation
  • Thryv Therapeutics Inc.
  • Toray Medical Co., Ltd.
  • Vanguard AG
  • Volta Medical
Product Code: MRR-436901065DB6

The Atrial Fibrillation Surgery Market was valued at USD 2.67 billion in 2023, expected to reach USD 2.90 billion in 2024, and is projected to grow at a CAGR of 9.00%, to USD 4.88 billion by 2030.

Atrial fibrillation (AF) surgery involves medical procedures designed to correct the irregular heartbeat associated with AF, often pursued when less invasive treatments fail. These surgeries, such as catheter ablation or the Maze procedure, are vital as AF can lead to serious complications like stroke or heart failure. The application extends to both symptomatic individuals and those at significant risk of complications, facilitated by hospitals and specialized cardiac centers. The global market for AF surgeries is primarily influenced by the rising prevalence of AF due to an aging population and increased awareness among patients and healthcare providers. Technological advancements in surgical procedures and equipment are opening new opportunities, with innovations like robotic-assisted surgeries and improved catheter designs holding potential to enhance outcomes and reduce recovery times. However, the high cost of these procedures and limited access in underdeveloped regions constrain market expansion. Regulatory challenges and the need for skilled professionals further complicate the landscape. To overcome these hurdles, strategic partnerships and collaborations for technology sharing and training could be key. In terms of research and innovation, areas such as AI-driven diagnostic and surgical planning tools, as well as improved monitoring systems post-surgery, present promising avenues for growth. Furthermore, enhancing insurance coverage and reimbursement frameworks may accelerate market development. The market is characterized by rapid technological advancements but also faces scrutiny from regulatory bodies, emphasizing the need for compliance and robust clinical validation. Companies must focus on value propositions that include cost-effective solutions and improved patient outcomes to capture market share. Overall, strategic investments in R&D, combined with efforts to broaden patient access and streamline procedural costs, are critical for sustained growth in the atrial fibrillation surgery market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.90 billion
Forecast Year [2030] USD 4.88 billion
CAGR (%) 9.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Atrial Fibrillation Surgery Market

The Atrial Fibrillation Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in prevalence of atrial fibrillation in geriatric population
    • Development in preference of catheter ablation for cardiac arrhythmia treatment
    • Growing number of AF programs to enhance public awareness
  • Market Restraints
    • Regulatory issues associated with the devices
  • Market Opportunities
    • Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
    • Technological advances for catheter ablation of atrial fibrillation
  • Market Challenges
    • Lack of skilled professionals and awareness among the people about the surgery

Porter's Five Forces: A Strategic Tool for Navigating the Atrial Fibrillation Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Atrial Fibrillation Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Atrial Fibrillation Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Atrial Fibrillation Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Atrial Fibrillation Surgery Market

A detailed market share analysis in the Atrial Fibrillation Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Atrial Fibrillation Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Atrial Fibrillation Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Atrial Fibrillation Surgery Market

A strategic analysis of the Atrial Fibrillation Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Cryoablation Catheters and Cardiac Mapping System.
  • Based on Indication, market is studied across Atrial Fibrillation (AFib), Atrial Flutter, and Supraventricular Tachycardia (SVT).
  • Based on End-User, market is studied across Cardiology and Multi Specialities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in prevalence of atrial fibrillation in geriatric population
      • 5.1.1.2. Development in preference of catheter ablation for cardiac arrhythmia treatment
      • 5.1.1.3. Growing number of AF programs to enhance public awareness
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory issues associated with the devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
      • 5.1.3.2. Technological advances for catheter ablation of atrial fibrillation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals and awareness among the people about the surgery
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
    • 5.2.2. Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
    • 5.2.3. End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Atrial Fibrillation Surgery Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Cryoablation Catheters
  • 6.3. Cardiac Mapping System

7. Atrial Fibrillation Surgery Market, by Indication

  • 7.1. Introduction
  • 7.2. Atrial Fibrillation (AFib)
  • 7.3. Atrial Flutter
  • 7.4. Supraventricular Tachycardia (SVT)

8. Atrial Fibrillation Surgery Market, by End-User

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Multi Specialities

9. Americas Atrial Fibrillation Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Atrial Fibrillation Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
    • 12.3.2. Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
    • 12.3.3. Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acesion Pharma ApS
  • 3. Acutus Medical, Inc
  • 4. Affera, Inc.
  • 5. AFreeze GmbH
  • 6. Atrian Medical Ltd.
  • 7. AtriCure, Inc.
  • 8. AuriGen Medical
  • 9. BIOTRONIK SE & CO. KG
  • 10. Boston Scientific Corporation
  • 11. Cardiofocus, Inc.
  • 12. CathRx Ltd
  • 13. Cook Group Incorporated
  • 14. F. Hoffmann-La Roche AG
  • 15. GE HealthCare Technologies Inc.
  • 16. Healium Medical
  • 17. Japan Lifeline Co.
  • 18. Johnson & Johnson Services, Inc.
  • 19. Kardium Inc.
  • 20. Koninklijke Philips N.V.
  • 21. Medtronic PLC
  • 22. OMEICOS Therapeutics GmbH
  • 23. Osypka AG
  • 24. SentiAR, Inc
  • 25. Siemens Healthcare GmbH
  • 26. Stryker Corporation
  • 27. Terumo Corporation
  • 28. Thryv Therapeutics Inc.
  • 29. Toray Medical Co., Ltd.
  • 30. Vanguard AG
  • 31. Volta Medical

LIST OF FIGURES

  • FIGURE 1. ATRIAL FIBRILLATION SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL FIBRILLATION SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ATRIAL FIBRILLATION SURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023